Treating Acute Leukemias
in Latin America

Bridging Science and Practice: From Newest Clinical Approaches to Real-World Clinical Cases

Register Now

Overview

This 2-day virtual program offers a comprehensive overview of the latest clinical updates and novel treatment strategies for acute leukemia, presented by experts. Attendees will have the opportunity to gain knowledge on optimal treatment of patients with leukemia, join patient case-based discussions, and interact with experts.

Register Now

Date and Location

August 27–28, 2025, Webinar

Register Now

Meeting Content

View the slides and watch the video of Day 1

View Slides Watch Video

View the slides and watch the video of Day 2

View Slides Watch Video

Chair

Elias Jabbour

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX, USA

Naval Daver

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX, USA

Faculty

Ibrihim Aldoss

Ibrahim Aldoss, MD

City of Hope, Duarte, CA, USA

Roberta Demichelis

Roberta Demichelis, MD

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,
Mexico City, Mexico

Aaron Logan

Aaron Logan, MD, PhD

University of California, San Francisco, San Francisco, CA, USA

Jae Park

Jae Park, MD

Memorial Sloan Kettering Cancer Center,
New York, NY, USA

 

José Maria Ribera

Josep-Maria Ribera, MD, PhD

Catalan Institute of Oncology, Badalona, Spain

Wellington Silva

Wellington Silva, MD, PhD

Hospital das Clínicas, São Paulo, Brasília

Agenda

This 2-day interactive virtual meeting with global experts will focus on the treatment of patients with acute leukemia in various countries within the LATAM region.

Day 1: Follow interactive presentations and case-based discussions with your peers on the latest updates for first-line assessments and treatments for adults and young adults with ALL, including the role of MRD, risk stratification, and tolerability and feasibility considerations. Engage with the faculty in panel discussions on optimal treatment and how first-line therapy will influence subsequent treatment options. Discuss regional case studies in newly diagnosed ALL with LATAM colleagues.

Day 2: Join to learn more about current state-of-the-art approaches for relapsed/refractory (R/R) ALL, and the evolving role of transplantation in LATAM. Discuss regional case studies in R/R ALL with LATAM colleagues and discuss challenges with treating elderly and/or frail patients. Interact with faculty during a panel discussion on patient access and regional challenges across the LATAM region.

Day 1: Virtual Plenary Sessions
Wednesday, August 27, 2025
4.00 PM – 7.00 PM UTC -6 Mexico City
5:00 PM – 8:00 PM UTC -5 (Houston/Bogotá)
7:00 PM – 10:00 PM UTC -3 (Brasília/Buenos Aires)

Time (UTC -3) Topic Presenter
7.00 PM –
7.10 PM		 Welcome and meeting overview; introduction to the voting system Elias Jabbour
7.10 PM –
7.35 PM		 Latest achievements and developments in ALL Elias Jabbour
7.35 PM –
7.55 PM		 Prognostic and predictive markers in ALL  
7.55 PM –
8.25 PM		 Best practices for first-line treatment in ALL Elias Jabbour
8.25 PM –
8.40 PM		 AYA patients with ALL: What is the current treatment approach for this diverse patient population? Special considerations for adolescents and young adults and how we can use this experience in adult patients  
8.40 PM –
8.50 PM		 Break  
8.50 PM –
9.25 PM

ALL case-based panel discussion for first-line therapy

  • Case ALL: Adult low risk
  • Case ALL: Adult high risk
  • Case ALL: AYA
 Local chair and local fellows
Panelists: All faculty
9.25 PM –
9.50 PM

Panel discussion: How treatment in first line influences further therapy approaches in ALL

  • Will CAR T and bispecifics change the treatment landscape?
  • Role of HSCT – is it still necessary?
  • What does the future look like? Adoption of therapies and evolving standards of care in LATAM

​

 Elias Jabbour and all faculty
9.50 PM –
10.00 PM		 Session close​ Elias Jabbour

Day 2: Virtual Plenary Sessions
Thursday, August 28, 2025
4.00 PM – 7.00 PM UTC -6 Mexico City
5.00 PM – 8.00 PM UTC -5 (Houston/Bogotá)
7.00 PM – 10.00 PM UTC -3 (Brasília/Buenos Aires)

Time (UTC -3) Topic Presenter
7.00 PM –
7.10 PM		 Welcome to Day 2 Elias Jabbour
7.10 PM –
7.30 PM		 Current treatment options for relapsed/refractory ALL in fit adults  
7.30 PM –
7.50 PM		 Long-term safety considerations for ALL  
7.50 PM –
8.10 PM		 Current and future role of transplantation in acute leukemias in Latin America  
8.10 PM –
8.20 PM		 Break  
8.20 PM –
8.40 PM		 Current treatment options for relapsed ALL in elderly and frail patients  
8.40 PM –
9.10 PM

ALL case-based panel discussion for R/R ALL

  • Case ALL: Young
  • Case ALL: Young but frail
  • Case ALL: Elderly
 All faculty
9.10 PM –
9.50 PM

Panel discussion: Open questions in ALL – regional challenges (transplant, CAR T, studies, and other)

  • What would be needed to make CAR T therapy available to your patients?
  • What would be needed to expand access to bispecifics?
  • How can the application of therapeutic innovations be expedited in LATAM?
 All faculty
9.50 PM –
10.00 PM		 Session close Elias Jabbour

Register Now